All mice were trained by treadmill running 5 times per week for 2

All mice were trained by treadmill running 5 times per week for 2 weeks.

SP was dissolved in distilled water and 800-mg/kg body weight daily doses and administered orally intraperitoneally before the running exercise to the SP group for 2 weeks [13–15]. The CON group was treated with vehicle only (distilled water 5 mL/kg body weight). was measured before and after the 2 weeks training period. We also evaluated energy Gemcitabine price metabolism during exercise for 1 h after the 2 weeks training period. Mice were fasted 3 h before the 1 h exercise. We obtained blood, liver glycogen, and gastrocnemius-white and red muscle samples at three time points: rest, immediately after exercise and 1 h post-exercise. The INCB28060 mice were fed ad libitum with a find more standard diet (5 L79; Orient Bio, Inc.) containing the following nutrients (g/kg diet): crude protein, 180; crude fat, 52; crude fiber, 52; minerals, 57; and carbohydrates, 368. The calorically based protein:fat:carbohydrate ratio (%) was 21:14:65, and the gross and metabolizable caloric contents of the diet were 4.04 and 3.21 Kcal/g, respectively. The body weights and food intake were monitored daily throughout

the experiment. All mice were housed in standard plastic cages under controlled humidity (50%) and temperature (23°C ± 1°C) conditions and with alternating 12-h light/dark cycles. All experimental procedures were performed at the Animal Experiment Research Center of Konkuk University. This study was conducted in accordance with the ethical guidelines of the Konkuk University Institutional Animal Care and Use Committee. Silk peptides SP were obtained from Worldway Co. Ltd. (Jeoneui, Korea). The SP primarily comprised amino acids in the following order of concentration: Ala (34.36%) > Gly (27.23%) > Iso (15.51%) > Ser

(9.58%) > minor amino acids. Composition 4��8C details are shown in Table 1. The SP composition according to molecular weight was as follows: an approximate range of 150–350 D and an average molecular weight of approximately 250 D. Table 1 Amino acid compositions (%) of SP Amino acid SP (silk peptide) Ala 34.36 Gly 27.23 Iso 15.51 Ser 9.58 Val 3.49 Thr 2.00 Asp 1.68 Glu 1.28 Ile 1.25 Leu 1.24 Phe 0.87 Pro 0.44 Tyr 0.41 His 0.21 Arg 0.17 Met 0.10 Lys 0.10 Cys 0.05 Trp 0.05 Sum 100.00 Training method Running mice were adapted to treadmill training (treadmill from Daejong Systems, Korea) at a fixed intensity (15 m/min, 8° slope) for 3 days. All mice were then tested for a certain period at a frequency of 5 times per week for a total of 2 weeks. The following protocols were used: 20 m/min, 8° slope, 50 min/day for the first week and 25 m/min, 8° slope, 50 min/day (about 75% of maximum ) for the second week [16].

interrogans serogroup Icterohaemorrhagiae serovar Lai strain Lai

interrogans serogroup Icterohaemorrhagiae serovar Lai strain Lai was offered by the National Institute for the Control of Pharmaceutical and Biological selleck compound Products in Beijing, China. The leptospires were cultured in Korthof liquid medium containing 8% heat-inactivated rabbit serum (RS) at 28°C. To maintain virulence, the strain was passaged intraperitoneally in

specific pathogen-free Dunkin-Hartley ICO:DH (Poc) guinea pigs (2 weeks old, each weighing about 120 g) before use, according to the description by Merien et al. and Viriyakosol et al. [44, 54]. Animal protocols were approved by the Animal Ethics Review Committee of Afatinib solubility dmso Zhejiang University. Cell line and culture The murine mononuclear-macrophage-like cell line (J774A.1) was learn more obtained from the American Type Culture Collection (Rockville, MD, USA). The cells were cultured in RPMI 1640 medium (GIBCO,

USA), supplemented with 10% heat-inactivated fetal calf serum (FCS) (GIBCO), 100 U/ml penicillin and 100 μg/ml streptomycin (Sigma, USA) at 37°C in an atmosphere of 5% CO2. PCR and sequencing Genomic DNA of L. interrogans strain Lai was extracted using Bacterial Genomic DNA Extraction Kit (BioColor, China). Plasmid pUC19, which has an ampicillin resistant gene (bla) cassette including promotor in E. coli DH5a, was prepared by Mini-plasmid Rapid Isolation Kit (BioDev, China). Primers for amplifications of the fliY and bla genes are shown in Table 2. A commercial PCR Kit (TaKaRa, China) was used to amplify the fliY and bla genes. The products were detected on 1.5% ethidium

bromide pre-stained agarose gel by electrophoresis, L-gulonolactone oxidase purified using PCR Product Purification Kit (BioColor), and ligated into plasmid pUCm-T using T-A Cloning Kit (BioColor) to form recombinant plasmids pUCm-T fliY . pUCm-T bla sequencing was performed by Invitrogen Co. Ltd in China. Table 2 Primer information for amplification of the fliY and bla genes. Gene Primer sequence (5′-3′) Product size fliY F: GCC GGA TCC (BamH I) ATG GGT GAA GGT TCC CTA TCA CAG 1065 bp   R: GCC AAG CTT (Hind III) TCA CTT ACC CTC CGG CTT AAT CCG   bla F: GCC AGA TCT (Bgl II) TCT AAA TAC ATT CAA ATA TGT 954 bp   R: GCC AGA TCT (Bgl II) CTT GGT CTG ACA GTT ACC AAT   fliP F: ATG AAA ATG AGA CAT AAA 804 bp   R: TCA TTT ATA ACT CCT TAC   fliQ F: ATG ACG GAA TTA GAC GTT ATG 264 bp   R: CTA AAA TTT TTC GAT CAT CAA   F: forward primer, R: reverse primer. Expression, purification and immunization of recombinant FliY pUCm-T fliY and expression vector pET32a (Novagen, USA) were digested with BamH I and Hind III, respectively. The recovered fliY segment was ligated into linearized pET32a using T4 DNA ligase (TaKaRa), and then transformed into E. coli BL21DE3 (Novagen) to form E. coli BL21DE3pET32a-fliY . Recombinant FliY (rFliY) was expressed under inducement of 0.5 mM IPTG for 4 h at 37°C. The expressed rFliY was extracted by Ni-NTA affinity chromatography and the purity of rFliY was determined by SDS-PAGE.

Recently, many of these studies have been assembled into collecti

Recently, many of these studies have been assembled into collection databases [2, 3] allowing analyses that examine RepSox cost patterns of essential genes across multiple organisms [4]. In organisms in which a genome wide essentiality survey has not been completed,

additional approaches have been used to predict essential genes. If gene essentiality has been determined in a closely related model organism, orthology between genes can predict shared essentiality [5–10]. Alternatively, systems biology approaches examine the global enzymatic and metabolic requirements of the organism. Among these are studies which define a minimal genome for a generic bacterial organism [11–13], or model the total metabolic interactions of the cell [14, 15]. For organisms with no functional genomics information in nearby species, methods based purely on gene sequence are being developed, though these provide lower accuracy than functional comparisons [16, 17]. Among the purely sequence based methods, gene conservation across taxa is the strongest indicator of gene essentiality [11, 16, 18, 19]. Genes whose protein sequences have been tightly conserved across lineages are assumed to be more likely to be important to the survival of the organism [20]. Each of the essential gene prediction methods described above requires different levels of a priori information about the target organism KU-57788 cost or closely related organisms.

As the amount of functional genomics information available decreases, predicting essential genes and drug targets becomes a significantly more difficult task. Here we present the results of our analysis of one such organism having no such functional data, the Wolbachia endosymbiont of Brugia malayi, (wBm). B. malayi is a parasitic filarial SCH727965 order nematode of humans which, along with Wuchereria bancrofti and Onchocerca volvulus, are the causative agents of lymphatic filariasis and onchocerciasis, more commonly known as elephantiasis and river blindness, respectively. Together, filarial parasites infect approximately 150 million people worldwide Metalloexopeptidase with 1.5

billion at risk of infection [21]. Current treatments utilize diethylcarbamazine, benzimidazoles (e.g., albendazole) and avermectins (e.g., ivermectin), however, these treatments are predominately only effective during the larval stages of the parasite [22]. Because the life-span of the adult worm is up to 15 years, long treatment courses are required to effectively eliminate the infection. Additionally, the emergence of drug resistance is becoming increasingly apparent [23, 24]. The α-proteobacterium Wolbachia is an obligate endosymbiont of most filarial nematodes, and in several, including B. malayi, is required for worm viability. Clearance of the Wolbachia by antibiotics results in worm growth retardation, infertility and killing, while antibiotic treatment of non-Wolbachia carrying nematode species has no effect [25, 26].

They require a large amount of catalase activity to reduce high c

They require a large amount of catalase activity to reduce high concentration of reactive oxygen species involved in the wood decay [44]. Comparative and evolutionary analysis, such as the above-mentioned

example, can be done on other families of peroxidases as well. Utility and discussion The web interface of fPoxDB provides an easy-to-use genomics environment. Intuitive menu structure and browsing system enable users to easily explore fPoxDB. fPoxDB provides browsing functions, gene distribution table and charts, pre-computed results of eight bioinformatics tools including InterPro scan [21], SignalP 3.0 [45], SecretomeP 1.0f [46], TMHMM 2.0c [47], PHA-848125 in vitro TargetP 1.1b [48], PSortII [49], ChloroP 1.1 [50], and predictNLS [51], as well as job submission forms for BLAST [41], HMMER [31], BLASTMatrix [32], and ClustalW [42] (Figure 3). In addition, the sequence profiles which were used in prediction of putative peroxidase genes can be downloaded, enabling large scale analysis such as whole proteome search Bortezomib on local computers. Figure 3 Web interface and functionalities. A) Web interface of fPoxDB displays well organized graphical charts for better recognition of the distribution of the genes. B) Tools including similarity search (BLAST [41], HMMER [31] and BLASTMatrix [32]) and multiple sequence alignment (ClustalW [42]) are provided

via the Favorite Browser. C) Protein domain analysis and TMH analysis can be also done with the sequences collected in Favorites. D) Users’ sequence collection can be further analysed by the tools available at the CFGP 2.0 [32] and other sister databases [39, 52–54]. Dynein “Browse by Species” displays species name, find more taxonomy, and the number of predicted peroxidase genes/gene families. For each species, the detail page shows the number of predicted

genes for each gene family as a graphical chart and table to present an overview on the peroxidase composition in a genome. The hierarchy implemented in the browser is easy to follow, so that users can readily retrieve data. “Browse by Species” also provides the taxonomically ordered summary table for every peroxidase family where kingdom-level and subphylum-level distribution are available. A summary of the whole database that describes the number of predicted genes against each genome can be downloaded as .csv format. This could provide the possibility to study gene family expansion or contraction across a number of genomes. “Browse by Classes” lists the peroxidase gene families and the number of genes and genomes corresponding to each gene family. Distribution of genes for each gene family is depicted in a box plot in order to show subphylum-level of taxonomic distribution at a glance. These distribution summaries could be used for searching peroxidase families which are limited to a certain range of taxonomy, such as LiP and MnP.

Cun Daily renal clearance rate of urea Fig  2 The

Cun Daily renal clearance rate of urea Fig. 2 The relationship between the amount of urinary excreted YM155 cost total protein and albumin (a), and the relationships between the amount of urinary excreted Klotho and urinary total protein (b) and that of urinary albumin (c) among PD patients. Note that there was a significant

association between the amount of urinary total protein and albumin The soluble Klotho excretion in the dialysate was also determined. Although there was one patient with a negative finding for Klotho, Klotho was detectable by ELISA in the dialysate of the remaining thirty-five patients. The amount of peritoneal excreted soluble Klotho in the 24-h dialysate collections ranged from 21.7 to 323.5 ng/day (median 113.7 ng/day; IR 76.9–155.1). There were significant correlations between the amount of peritoneal Klotho excretion and those of total protein and albumin (Fig. 3a, b). We also confirmed that a significant relationship existed between the amount of total protein and that of albumin in the dialysate (Fig. 3c). An IB analysis demonstrated the presence of soluble Klotho in the dialysate Saracatinib molecular weight derived from the patient with the highest Klotho concentration (Fig. 3d). We failed to confirm a statistically significant relationship

between the amount of peritoneal soluble Klotho and the single-day peritoneal KT/V (r = −0.163, Selleckchem BIBF 1120 p = 0.35). Fig. 3 The relationships between

the amount of peritoneal Klotho excretion and those of total protein (a) and albumin (b) in the dialysate, and the relationship between the amount of peritoneal total protein and that of albumin (c). d The presence of soluble Klotho was demonstrated by immuno-blotting (IB) with KM2076 in the peritoneal dialysate samples with the highest Klotho concentration, of 122.7 pg/ml (lane 1), and the second-highest Klotho concentration, below of 54.4 pg/ml (lane 2). In the sample from the patient with a Klotho concentration of 21.1 pg/ml, no band was detectable (lane 3). Note that the densities of the bands seemed to correspond to the soluble Klotho concentrations Discussion The present study has clearly demonstrated, for the first time, that the urinary excreted soluble Klotho, but not the serum Klotho concentration, is positively correlated with approximations of the residual renal function, including the urine output, urinary Ccr, and the average urinary Ccr + Cun [13, 14], among patients undergoing PD treatment. The urine output among patients with chronic renal failure may be variable, ranging from oliguria to normal or even above normal levels, because it is determined not only by the glomerular filtration rate (GFR), but also by numerous pathophysiological mechanisms, such as changes in the rate of tubular reabsorption [15].

The thin film PDMS pattern with a thickness of 200 μm, a width of

The thin film PDMS pattern with a thickness of 200 μm, a width of 200 μm, and a total length of 15.8 cm on the PET substrate was prepared using a laser and used as template. The synthesized

OSC ink with blue dye (seen more Sapanisertib clinical trial clearly) was dropped to the center of the template using a syringe (20 μL per drop). Due to the good wetting and film-forming ability of the ink, it will flow along the template track until it fills the whole track, especially after plasma buy SNX-5422 treatment with oxygen. After sintering at 120°C for 30 s, the continuous conductive track can be fabricated, and the total resistor R ab decreased to 4.6 Ω measured by a multimeter (middle image of Figure  5) with a width of 200 μm and thickness of 22 μm according to the surface profile. Conclusions In summary, an unusual kind of high-efficiency, transparent organic silver conductive ink (OSC ink) was synthesized with silver acetate as silver carrier, ethanolamine as additive, and different kinds of aldehyde-based materials as reduction

agents successfully. The results show that different reduction agents have an important 3-Methyladenine mouse influence on the ink properties through a series of complex chemical reactions, and when formic acid or dimethylformamide was used as the reduction agent and sintered at 120°C for 30 s, the resistivity can be lowered down to 6 to 9 μΩ·cm. It also can be obtained that the fabricated conductive pattern shows good temperature and dynamic fatigue properties. Besides, the feasibility of the synthesized OSC ink was verified through the preparation of an antenna pattern using drop or fit-to-flow method successfully. Acknowledgments This work was supported by the project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). References 1. Chen Y, Au J, Kazlas P, Ritenour A, Gates H, McCreary M: Flexible

active-matrix electronic ink display. Nature 2003, 423:136.CrossRef 2. Bairavasubramanian R, Thompson D, Ponchak GE, Tentzeris MM, Papapolymero-u J: Liquid EGFR inhibitor crystal polymer (LCP): a new organic material for the development of multilayer dual-frequency/dual-polarization flexible antenna arrays. IEEE Anten Wirel Pr 2005, 4:22–26.CrossRef 3. Otte K, Makhova L, Braun A, Konovalov I: Flexible Cu(In, Ga) Se2 thin-film solar cells for space application. Thin Solid Films 2006, 511:613–622.CrossRef 4. Baeg KJ, Khim D, Kim J, Yang BD, Kang M, Jung SW: High-performance top-gated organic field-effect transistor memory using electrets for monolithic printed flexible NAND flash memory. Adv Funct Mater 2012, 22:2915–2926.CrossRef 5. Nishide H, Oyaizu K: Toward flexible batteries. Science 2008, 319:737–738.CrossRef 6. Meng Y, Zhao Y, Hu C, Cheng H, Hu Y, Zhang Z, Shi G, Qu L: All-graphene core-sheath microfibers for all-solid-state, stretchable fibriform supercapacitors and wearable electronic textiles. Adv Mater 2013, 25:2326–2331.CrossRef 7.

Protein expression was induced by isopropyl-β-D-thiogalactopyrano

Protein expression was induced by isopropyl-β-D-thiogalactopyranoside (IPTG), and purification of the three recombinant proteins was achieved through nickel affinity chromatography with the HisTrapTM

HP column. Each purified protein migrated as a single band with the predicted size in SDS-PAGE, of which purity was more than 95% (Figure 1). The specifiCity of the bands was confirmed by using specific antibodies generated against native forms of Prn, Fim2 or Fim3, respectively, in Western blotting (Figure 1). By using this approach, a large amount of proteins was obtained, at approximately 12 mg/L of rPrn, 25 mg/L of rFim2, and 19 mg/L of rFim3. Figure 1 SDS-PAGE and Western blotting analysis. (A) SDS-PAGE of the purified recombinant proteins. The proteins were electrophoresed on a 10% SDS-PAGE gel under reducing condition and buy Ricolinostat stained by Coomassie blue. Lane 1: Molecular mass marker, the molecular mass standards are

indicated in kDa on left LB-100 ic50 side; lane 2: rPrn (10 μg); lane3: rFim2 (10 μg); lane 4: rFim3 (10 μg). (B) Western blotting of the recombinant proteins. Lane 1: Pre-stained molecular mass marker (170 kDa, 130, 100, 70, 55, 40, 35, 25, 15, 10, Fermentas), the molecular mass standards are indicated in kDa on left side; lane 2: rFim2 was detected with mouse anti-Fim2 monoclonal antibodies; lane 3: rFim3 was detected with mouse anti-Fim3 monoclonal antibodies; lane 4: Pre-stained molecular mass marker, the molecular mass standards are indicated in kDa on right side; lane 5: rPrn was detected with mouse anti-Prn monoclonal antibodies; lane 6: Pre-stained molecular mass marker, the molecular mass standards are indicated in kDa on right side. Serum antibody responses

to rPrn, rFim2 and rFim3 In order to examine the antibody DMXAA cell line responses to rPrn, rFim2 and rFim3, sera of immunized mice were collected two weeks after the second immunization. Titres of serum IgG antibodies were measured by ELISA. Significant IgG antibody responses were observed in the mice immunized Verteporfin nmr with both high and low doses of rPrn, rFim2 or rFim3 when compared to the control group (P < 0.001 for all three proteins) (Figure 2). High levels of IgG antibodies were induced in mice immunized with high doses of the three proteins. However, the differences were not significant when compared to those in mice immunized with low doses (Figure 2). When the same amount of rFim2 and rFim3 was used in immunization, IgG responses appeared to be similar between the two groups (P = 0.056). Figure 2 Antibody responses in immunized and control mice. Two weeks after the second immunization, sera were collected, and IgG antibody titres were determined by ELISA. Results represent the mean antibody titres for five mice per group. An asterisk symbol (*) indicates a statistically significant difference (P < 0.001) between immunized and control group.

FEMS Microbiol Rev 1999, 23:615–627 PubMedCrossRef 43 Garcin E,

FEMS Microbiol Rev 1999, 23:615–627.PubMedCrossRef 43. Garcin E, Vernede X, Hatchikian EC, Volbeda A, Frey M, Fontecilla-Camps JC: The NF-��B inhibitor crystal structure of a reduced [NiFeSe] hydrogenase Compound C provides an image of the activated catalytic center. Structure (London, England: 1993) 1999,7(5):557–566.CrossRef 44. Heider J, Böck A: Selenium metabolism in microorganisms. Adv Microb Physiol 1993, 35:71–109.PubMedCrossRef 45. Macy JM, Rech S, Auling G, Dorsch M, Stackebrandt E, Sly LI: Thauera selenatis gen. nov., sp. nov., a member of the beta subclass of Proteobacteria with a novel type of anaerobic respiration. Int J Syst Bacteriol 1993,43(1):135–142.PubMedCrossRef 46. Trieber CA,

Rothery RA, Weiner JH: Engineering Panobinostat a novel iron-sulfur cluster into the catalytic subunit of Escherichia coli dimethyl-sulfoxide reductase. Journal of Biological Chemistry 1996,271(9):4620–4626.PubMedCrossRef 47. DeMoll-Decker H, Macy JMT: The periplasmic nitrite reductase of Thauera selenatis may catalyse the reduction of Se(IV) to elemental selenium. Arch Microbiol 1993, 160:241–247. 48. Harrison G, Curle C, Laishley EJ: Purification and characterization of an inducible dissimilatory type sulfite reductase from Clostridium pasteurianum . Arch Microbiol 1984, 138:72–78.PubMedCrossRef 49. Mukhopadhyay R, Rosen BP, Phung LT, Silver S: Microbial arsenic: from geocycles to genes and enzymes. FEMS Microbiol Rev

2002,26(3):311–325.PubMedCrossRef 50. Rosen BP: Biochemistry of arsenic detoxification. FEBS Lett 2002, 529:86–92.PubMedCrossRef 51. Stolz JF, Basu P, Santini JM, Oremland RS: Arsenic and selenium in microbial metabolism. Annual Review of Microbiology 2006,60(1):107–130.PubMedCrossRef 52. Moreno-Vivian C, Cabello P, Martinez-Luque M, Blasco R, Castillo F: Prokaryotic nitrate reduction: molecular properties Coproporphyrinogen III oxidase and functional distinction among bacterial nitrate reductases. J Bacteriol 1999,181(21):6573–6584.PubMed 53. Gerritse J, Drzyzga O, Kloetstra G, Keijmel M, Wiersum LP,

Hutson R, Collins MD, Gottschal JC: Influence of different electron donors and acceptors on dehalorespiration of tetrachloroethene by Desulfitobacterium frappieri TCE1. Appl Environ Microbiol 1999,65(12):5212–5221.PubMed 54. Milliken CE, Meier GP, Watts JEM, Sowers KR, May HD: Microbial anaerobic demethylation and dechlorination of chlorinated hydroquinone metabolites synthesized by Basidiomycete fungi. Appl Environ Microbiol 2004,70(1):385–392.PubMedCrossRef 55. Christiansen N, Ahring BK: Introduction of a de novo bioremediation activity into anaerobic granular sludge using the dechlorinating bacterium DCB-2. Antonie Van Leeuwenhoek 1996,69(1):61–66.PubMedCrossRef 56. Smidt H, van Leest M, van der Oost J, de Vos WM: Transcriptional regulation of the cpr gene cluster in ortho -chlorophenol respiring Desulfitobacterium dehalogenans . J Bacteriol 2000, 182:5683–5691.PubMedCrossRef 57.

Virulence 2010, 1:359–366 PubMedCrossRef 4 Hamza OJM, Matee MI,

Virulence 2010, 1:359–366.PubMedCrossRef 4. Hamza OJM, Matee MI, Moshi MJ, Simon EN, Mugusi F, Mikx FH, Heldermana WH, Rijs AJ, van Lorlatinib in vivo der Ven AJ, Verweij PE: Species distribution and in vitro antifungal susceptibility of oral yeast isolates from Tanzanian HIV infected patients with primary and recurrent oropharyngeal candidiasis. BMC Microbiology 2008, 8:135.PubMedCrossRef 5. Silva S, Henriques M, Oliveira R, Williams D, Azeredo J: In vitro biofilm activity of non- Candida

albicans Candida species. Current Microbiology 2010, 61:534–540.PubMedCrossRef 6. Silva S, Negri M, Henriques M, Oliveira R, Williams D, Azeredo J: Silicone colonization by non- Candida albicans Candida species in the presence of urine. Journal of Medical Microbiology 2010, 59:747–754.PubMedCrossRef 7. Noumi E, Snoussi M, Hentati H, Mahdouani K, del Castillo L, Valentin E, Sentandreu R, Bakhrouf A: Adhesive properties and hydrolytic enzymes of oral Candida albicans strains. Mycopathologia 2010, 169:269–278.PubMedCrossRef 8. Nobile CJ, Nett JE, Andes DR, Mitchell AP: Function of Candida albicans adhesion Hwp1 in biofilm formation. Eukaryotic Cell 2006, 5:1604–1610.PubMedCrossRef 9. Seneviratne CJ, Silva WJ, Jin LJ, Samaranayake YH, Samaranayake LP: Architectural analysis, viability assessment and CHIR98014 growth kinetics of Candida albicans and Candida glabrata biofilms. Archives of Oral Biology 2009, 54:1052–1060.PubMedCrossRef 10. Chamilos G, Lionakis MS, Lewis RE,

Kontoyiannis DP: Role of mini-host models in the study of medically important fungi. Lancet Infectious Diseases 2007, 7:42–55.PubMedCrossRef 11. Mylonakis E, Aballay A: Worms and flies as genetically tractable animal models to study host-pathogen interactions. Infection and Immunity 2005, 73:3833–3841.PubMedCrossRef 12. Fuchs BB, Mylonakis E: Using non-mammalian hosts to study fungal virulence and host defense. Current Opinion in Microbiology 2006, 9:346–351.PubMedCrossRef 13. Mylonakis E: Galleria mellonella and the study of fungal pathogenesis: making the case for another genetically tractable model host. Mycopathologia 2008, 165:1–3.PubMedCrossRef 14. Bergin D, Murphy L, Keenan J, Clynes M, Kavanagh K: Pre-expose of yeast

protects larvae of Galleria mellonella from a subsequent lethal infection by Candida albicans and is mediated by the increased expression of antimicrobial TCL SAHA HDAC molecular weight peptides. Microbes and Infection 2006, 8:2105–2112.PubMedCrossRef 15. Rowan R, Moran C, McCann M, Kavanagh K: Use of Galleria mellonella larvae to evaluate the in vivo anti-fungal activity of [Ag 2 (mal)(phen) 3 ]. Biometals 2009, 22:461–467.PubMedCrossRef 16. Mowlds P, Kavanagh K: Effect of pre-incubation temperature on susceptibility of Galleria mellonella larvae to infection by Candida albicans . Mycopathologia 2008, 165:5–12.PubMedCrossRef 17. Fuchs BB, Eby J, Nobile CJ, El Khoury JB, Mitchell AP, Mylonakis E: Role of filamentation in Galleria mellonella killing by Candida albicans .

Nanotechnology 2007, 18:435504 CrossRef 10

Gordymova TA,

Nanotechnology 2007, 18:435504.CrossRef 10.

Gordymova TA, Davydov AA, Efremov AA: Ammonia and propylene complex formation on antimony oxide. React Kinet Catal Lett 1983, 22:143–146.CrossRef 11. Wang R, Zhang D, Sun W, Han Z, Liu C: A novel aluminum-doped carbon nanotubes sensor for carbon monoxide. J Mol Struct (THEOCHEM) 2007, 806:93–97.CrossRef 12. Omaye ST: Metabolic modulation of carbon TPX-0005 research buy monoxide toxicity. Toxicology 2002, 180:139–150.CrossRef 13. Roberts GP, Youn H, Kerby RL: CO-sensing mechanisms. Microbiol Mol Biol Rev 2004, 68:453–473.CrossRef 14. Dong KY, INK1197 datasheet Ham DJ, Kang BH, Lee K, Choi J, Lee JW, Choi HH, Ju BK: Effect of plasma treatment on the gas sensor with single-walled carbon nanotube paste. Talanta 2012, 89:33–37.CrossRef 15. Kong J, Franklin NR, Zhou C, Chapline MG, Peng S, Cho K, Dai H: Nanotube molecular wires as chemical sensors. Science 2000, 287:622–625.CrossRef 16. Zhao K, Buldum A, Han J, Lu P: Gas molecule adsorption in carbon nanotubes and nanotube bundles. Nanotechnology 2002, 13:195–200.CrossRef 17. Poulin P, Vigolo B, Launois P: Films and fibers of oriented single wall nanotubes. Carbon 2002, 40:1741–1749.CrossRef 18. O’Connell MJ, Bachilo SM, Hoffman XB, Moore VC, Strano MS, Haroz

EH, Rialon KL, Boul PJ, Noon WH, Kittrell C, Ma J, Hauge RH, Weisman RB, Smalley RE: Band gap fluorescence from individual single-walled carbon nanotubes. Science 2002, 297:593–596.CrossRef 19. Kauffman DR, Star A: Carbon SAHA HDAC nanotube gas and vapor sensors. Angew Chem Int Ed 2008, 48:6550–6570.CrossRef Phloretin 20. Wanna Y, Srisukhumbowornchai N, Tuantranont A, Wisitsoraat A, Thavarungkul N, Singjai P: The effect of carbon nanotube dispersion on CO gas sensing characteristics of polyaniline gas sensor.

J Nanosci Nanotechnol 2006, 6:3893–3896.CrossRef 21. Esumi K, Ishigami M, Nakajima A, Sawada K, Honda H: Chemical treatment of carbon nanotubes. Carbon 1996, 34:279–281.CrossRef 22. Hamon MA, Chen J, Hu H, Chen Y, Itkis ME, Rao AM, Eklund PC, Haddon RC: Dissolution of single-walled carbon nanotubes. Adv Mater 1999, 11:834–840.CrossRef Competing interest The authors declare that they have no competing interests. Authors’ contributions The work presented here was carried out in collaboration among all authors. KYD, HHC, and BKJ defined the research theme. KYD, JC, and YDL designed the methods and experiments, carried out the laboratory experiments, analyzed the data, interpreted the results, and wrote the paper. BHK and YYY worked on the associated data collection and their interpretation, and wrote the paper. KYD, HHC and BKJ designed the experiments, discussed the analyses, and wrote the paper. All authors read and approved the final manuscript.”
“Background Quantum dot-sensitized solar cells (QDSSCs) have attracted increasing attention due to their relatively low cost and potentials to construct high-efficiency energy conversion systems [1].